INGENIUM PHARMACEUTICALS AG
Ingenium Pharmaceuticals AG is discovers and develops molecules for the treatment of neuronal and autoimmune diseases.
INGENIUM PHARMACEUTICALS AG
Social Links:
Industry:
Biotechnology
Founded:
1997-01-01
Address:
Planegg, Bayern, Germany
Country:
Germany
Website Url:
http://www.probiodrug.de
Total Employee:
1+
Status:
Active
Contact:
+49 89 8565 2300
Total Funding:
43.98 M USD
Similar Organizations
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Avid Radiopharmaceuticals
Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.
Neurofix
Neurofix mission is to discover and develop molecules for the treatment of pathologies of the central nervous system.
Investors List
Thuja Capital
Thuja Capital investment in Venture Round - Ingenium Pharmaceuticals AG
German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF) investment in Grant - Ingenium Pharmaceuticals AG
New Medical Technologies
New Medical Technologies investment in Series B - Ingenium Pharmaceuticals AG
Lehman Brothers
Lehman Brothers investment in Series B - Ingenium Pharmaceuticals AG
Index Ventures
Index Ventures investment in Series B - Ingenium Pharmaceuticals AG
IKB Deutsche Industriebank
IKB Deutsche Industriebank investment in Series B - Ingenium Pharmaceuticals AG
Sofinnova Partners
Sofinnova Partners investment in Series B - Ingenium Pharmaceuticals AG
Bayern Kapital
Bayern Kapital investment in Series B - Ingenium Pharmaceuticals AG
Schroder Ventures
Schroder Ventures investment in Series B - Ingenium Pharmaceuticals AG
Deutsche Bank
Deutsche Bank investment in Series B - Ingenium Pharmaceuticals AG
Official Site Inspections
http://www.probiodrug.de
- Host name: dd53506.kasserver.com
- IP address: 85.13.129.136
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Ingenium Pharmaceuticals AG"
Probiodrug AG becomes Vivoryon Therapeutics AG - Vivoryon
Jun 12, 2019 Healthy Aging – Pioneering Innovation. HALLE (SAALE), Germany, 12 June 2019 – Probiodrug AG (Euronext Amsterdam: currently PBD, to be changed to VVY, ISIN: …See details»
Vivoryon Therapeutics - Home
Vivoryon Therapeutics is a precision medicine company focused on bringing first-in-class therapies to patientssuffering from age-related diseases.See details»
Aus Probiodrug AG wird Vivoryon Therapeutics AG
Aus Probiodrug AG wird Vivoryon Therapeutics AG Healthy Aging – Pioneering Innovation HALLE (SAALE), Deutschland, 12. Juni 2019 – Die Probiodrug AG (Euronext Amsterdam: Derzeit …See details»
Probiodrug AG becomes Vivoryon Therapeutics AG - BioSpace
Healthy Aging - Pioneering Innovation. HALLE (SAALE), Germany, 12 June 2019 – Probiodrug AG (Euronext Amsterdam: currently PBD, to be changed to VVY, ISIN: DE0007921835), …See details»
Probiodrug - VentureRadar
Enterome France Privately Held Enterome is a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to de-code molecular interactions in the gut …See details»
Probiodrug AG - Halle (Saale), Germany - bionity.com
Nov 30, 2012 Probiodrug is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal, inflammatory, and autoimmune …See details»
Probiodrug AG - Halle (Saale), Deutschland - bionity.com
Jun 1, 2016 probiodrug.de +493455559900. Teilen. Xing Linkedin Facebook X E-mail Loading... Merken. Merkliste aufrufen; Merken. Probiodrug AG. Weinbergweg 22 06120 Halle (Saale) ...See details»
Probiodrug AG | Halle, SA, Deutschland Startup - gust.com
Website probiodrug.de; Company Summary Probiodrug discovers and develops novel drugs for neuronal diseases. Its patent portfolio provides a dominant position for glutaminyl cyclase …See details»
Probiodrug - Overview, News & Competitors | ZoomInfo.com
Probiodrug - Business Information. Organizations · Germany · <25 Employees. Headquartered in Halle (Saale), Germany, Probiodrug AG (Euronext Amsterdam: PBD) is a clinical stage …See details»
Probiodrug: Governance, Directors and Executives & Committees ...
Former Officers and Directors: Probiodrug. Insider. Positions held. Since Until. Kugan Sathiyanandarajah: Director/Board Member 2023-05-31 2024-03-14 Morten Karsdal: …See details»
Company Probiodrug AG Euronext Amsterdam
Dec 31, 2006 Business description: Probiodrug AG Vivoryon Therapeutics N.V. specializes in the research and development of therapeutic products for the treatment of Alzheimer disease. …See details»
Probiodrug AG - Profile
Probiodrug’s lead product candidate, PQ912, is a highly specific and potent inhibitor of Glutaminyl Cyclase (QC), which has shown therapeutic effects in Alzheimer’s animal models. PQ912 is …See details»
Probiodrug heißt jetzt Vivoryon Therapeutics | CHEManager
Jun 12, 2019 Probiodrug hat sich mit der Eintragung in das Handelsregister Stendal zum 11. Juni 2019 offiziell in Vivoryon Therapeutics umbenannt. Laut CEO Ulrich Dauer steht der neue …See details»
Probiodrug AG | Science2Media
Die Probiodrug AG mit Hauptsitz in Halle, Deutschland, ist ein biopharmazeutisches Unternehmen mit dem Tätigkeitsschwerpunkt der Entwicklung neuer Therapieansätze für die Behandlung …See details»
Probiodrug AG - News, Articles etc. - European Pharmaceutical …
Oct 13, 2014 Probiodrug AG, a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s Disease, announces that Prof. Hans-Ulrich Demuth, co- founder …See details»
Probiodrug AG, has won a grant €1.9 million from KMU innovativ ...
Jun 25, 2008 Probiodrug AG, a spin-off from the Leibniz Society’s Hans-Knöll-Institut für Wirkstoffforschung in Jena and a specialist in the development of small molecule inhibitors for …See details»
Probiodrug AG Raises Additional EUR 15 Million to Advance Its …
Jan 4, 2012 For more information, please visit www.probiodrug.de. Company Contact: Kumar Srinivasan, Ph.D.CBOProbiodrug+49 345 55599-00+1 610 628 0238 (USA)[email protected]See details»
Wirkstoff getestet: Probiodrug aus Halle will Alzheimer besiegen
Aug 1, 2017 Probiodrug begann als reines Pharmaforschungsunternehmen - und mauserte sich zur Jahrtausendwende zu einem Leuchtturm unter den innovativen Firmen Ostdeutschlands. …See details»
Governance Probiodrug AG Euronext Amsterdam
71307aab33c0d272.Dzek_80bmHwhYi4K7iFG-Lw8vPTCPda5_lgYbkHXrPI.PHjmzbsj7y5LLGlrhlEZkuNm772heI7dygtTLRe9_q1ffOyxpFr0K0UjWQ …See details»
C21ORF2 mutations point towards primary cilia dysfunction in ...
2 days ago C21ORF2 has been implicated in actin cytoskeleton organization and DNA repair via interacting with NIMA-related kinase 1 (NEK1), another ALS gene of which rare variants have …See details»